Trishula Therapeutics Appoints Anil Singhal as Chief Executive Officer

    NEXT STORY
    India Molecular Diagnostics Market to 2026 by Application (Infectious Disease, Blood Screening, Genetic Testing, Oncology Testing) & Technology (PCR, In-situ Hybridization, Chips & Microarrays)
    PREV STORY
    Outlook on the Biosimilars Global Market to 2026 – Patent Expirations of Major Biologics Leads Way for Biosimilars
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    VIFOR PHARMA FERROPORTIN INHIBITOR ENTERS PHASE-I CLINICAL TRIAL

    vifor pharma announced today that vit-2763, the first-ever oral ferroportin inhibitor for preventing iron ...

    author_avatar
    NASDAQ Market News

    BioStem Technologies Inc. Enter into Agreement with Barbara Krutchkoff, PhD. To Guide Scientific Affairs

    Pompano Beach, FL, March 09, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC: BSEM) ...

    author_avatar
    NASDAQ Market News

    NANOBIOTIX announces first positive Human data showing that NBTXR3 could become a backbone in Immuno-Oncology

       NANOBIOTIX ANNOUNCES FIRST POSITIVE HUMAN DATA SHOWING THAT NBTXR3 COULD BECOME A BACKBONE ...

    author_avatar
    NASDAQ Market News